Clinical Trials
93 trialsTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
EVEREST-2
A2 Biotherapeutics Inc.
A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers
National Institutes of Health Clinical Center (CC)
TTBF
University of California, San Francisco
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
Revolution Medicines, Inc.
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Kestrel Therapeutics, Inc.
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
ModeX Therapeutics, An OPKO Health Company
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Revolution Medicines, Inc.
Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
Ohio State University Comprehensive Cancer Center
Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies
National Institutes of Health Clinical Center (CC)
ART-Hypo
Centre hospitalier de l'Université de Montréal (CHUM)
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
GlaxoSmithKline
First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined Cancers
Accent Therapeutics
Improving Care for Rural Patients With Solid Tumors
University of Colorado, Denver
SYLVER
GlaxoSmithKline
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
Novartis
Contribution of Preserving the Superior Left Colic Artery to the Vascularization of the Descending Colon Prior to Colorectal Anastomosis During Left-Sided or Rectal Resections for Colorectal or Ovarian Cancer. (Revascularisation Colique)
Institut du Cancer de Montpellier - Val d'Aurelle
AYAConnect
UNC Lineberger Comprehensive Cancer Center
FIDURA
Sahlgrenska University Hospital
AMPLIFY-201
Elicio Therapeutics
COCHISE
Institut Bergonié
A Study of LY2880070 in Participants With Advanced or Metastatic Cancer
Esperas Pharma Inc.
TOASTIT
Mayo Clinic
Abdominopelvic Cancer Prehabilitation
Universitat Jaume I
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Stanford University
SPIRIT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
UTC Therapeutics Inc.
PILLAR
Jules Bordet Institute
Interventions for the Management of Perineal Cancer Pain
Assiut University
PANO
Dublin City University
HETERERO
Charite University, Berlin, Germany
CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers
Corvus Pharmaceuticals, Inc.
ASPIRE
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study
M.D. Anderson Cancer Center
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Klus Pharma Inc.
GASVERT
Institut de Cancérologie de Lorraine
A Phase I Clinical Trial of Bevacizumab Injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma
MacroGenics
Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites
Jerome Canady Research Institute for Advanced Biological & Technological Sciences
IRIS
Stryker Orthopaedics
OPNRP
Ohio State University Comprehensive Cancer Center
Examining the Role of Transrectal High Intensity Focused Ultrasound (HIFU) in Rectal Pelvic Cancer
Imperial College London
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Abramson Cancer Center at Penn Medicine
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers
City of Hope Medical Center
Exploring HIFU as a Treatment for Rectal and Other Pelvic Cancers
Imperial College London
Prospective Analysis of Robot-Assisted Surgery
Instituto do Cancer do Estado de São Paulo
[F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers
University of Iowa
OCCPI
Ohio State University Comprehensive Cancer Center